Efficacy of GLP-1 receptor agonists for steroid-induced hyperglycemia in patients with diabetes

Efficacy of GLP-1 receptor agonists for steroid-induced hyperglycemia in patients with diabetes - Efficacy of GLP-1 receptor agonists for steroid-induced hyperglycemia in patients with diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000034083

Enrollment

Registered

2018-10-01

Start date

2018-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

treat patients with insulin treat patients with insulin and GLP-1 receptor agonists

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Subjects with diabetes 2) Subjects who routinely take oral or intravenous steroids 3) Subjects who agree to participate in the study with oral and written informed consent

Exclusion criteria

Exclusion criteria: 1) Subjects who refuse to participate in the study 2) Subjects who type 1 diabetes 3) Subjects with insulin-dependent diabetes 4) Subjects who used GLP-1 receptor agonists within one month 5) Subjects who are critically ill 6) Subjects who have difficulty participating in the study

Design outcomes

Primary

Measure	Time frame
Glycemic control and total daily insulin dose	—

Secondary

Measure	Time frame
Glycemic variation, adverse events including hypoglycemia, body weight, blood pressure, and lipid profile	—

Countries

Japan

Contacts

Public ContactSatoshi Yoshiji

Tazuke Kofukai Medical Research Institute, Kitano Hospital Center for diabetes and endocrinology

s-yoshiji@kitano-hp.or.jp06-6312-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026